Page 1 of Clinical Trials for Drug peginterferon alfa-2a Pegasys, 390 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Last Updated: November 7, 2011
Condition(s): Hepatitis C, Chronic
2
Recruiting
Telaprevir in Combination With Peginterferon and Ribavirin in Treatment-experienced Black/African American Subjects.
Last Updated: May 18, 2012
Condition(s): Hepatitis C
3
Recruiting
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Last Updated: May 18, 2012
Condition(s): Hepatitis C
4
Recruiting
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Last Updated: April 30, 2012
Condition(s): Hepatitis C Virus
5
Completed
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.
Last Updated: September 3, 2010
Condition(s): Hepatitis C Virus; Chronic Liver Disease; Viral Hepatitis; Therapeutic Uses; Antiviral Agents
6
Completed
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
Last Updated: June 22, 2011
Condition(s): Chronic Hepatitis C
7
Completed
Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
Last Updated: June 22, 2011
Condition(s): Chronic Hepatitis C
8
Recruiting
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Last Updated: May 18, 2012
Condition(s): Hepatitis C
9
Completed
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.
Last Updated: June 1, 2010
Condition(s): Hepatitis C, Chronic
10
Active, not recruiting
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment
Last Updated: April 30, 2012
Condition(s): Hepatitis C Virus
11
Completed
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Last Updated: March 22, 2012
Condition(s): Hepatitis C; HIV Infections
12
Completed
Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Last Updated: August 29, 2007
Condition(s): Hepatitis C, Chronic
13
Completed
A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C
Last Updated: June 22, 2011
Condition(s): Hepatitis C
14
Completed
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Last Updated: January 12, 2010
Condition(s): Chronic Hepatitis C; Cirrhosis, Liver; Fibrosis, Liver; Hepatic Cirrhosis
15
Active, not recruiting
Study of DEB025/Alisporivir Plus Pegylated Interferon alfa2a and Ribavirin and Boceprevir Plus Pegylated Interferon alfa2a and Ribavirin in African American Chronic Hepatitis C Genotype 1 Patients That Have Never Received Treatment for Their Hepatitis C
Last Updated: April 20, 2012
Condition(s): Hepatitis C; Liver Disease
16
Terminated
Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients
Last Updated: June 23, 2010
Condition(s): Chronic Hepatitis C
17
Recruiting
A Study to Compare the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) to Standard of Care in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Last Updated: May 21, 2012
Condition(s): Chronic Hepatitis C Virus
18
Completed
Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
Last Updated: June 12, 2007
Condition(s): HCV Infection; Hepatitis C, Chronic
19
Recruiting
Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Last Updated: May 2, 2012
Condition(s): Hepatitis C; Liver Transplant Recipient
20
Recruiting
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Last Updated: May 18, 2012
Condition(s): Hepatitis C, Chronic

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+peginterferon+alfa-2a+Pegasys

Page 1 of Clinical Trials for Drug peginterferon alfa-2a Pegasys, 390 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About